SCIENTIFIC HUB

Follow the evidence.

15.097 articles found

Open access

Lrrk2 G2019S mutation incites increased cell-intrinsic neutrophil effector functions and intestinal inflammation in a model of infectious colitis.

Pei J, Oliveira NL, Recinto SJ, Kazanova A, Queiroz-Junior CM, Li Z, Couto K, Westfall S, Fahmy AM, Tiefensee-Ribeiro C, King IL, Milnerwood AJ, Desjardins M, Thanabalasuriar A, Stratton JA, Gruenheid S.

NPJ Parkinsons Dis · 2025-08-29

DOI: 10.1038/s41531-025-01077-xPMID: 40883285

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Recombinant cathepsins B and L promote α-synuclein clearance and restore lysosomal function in human and murine models with α-synuclein pathology.

Balta D, Varghese A, Prieto Huarcaya S, Di Spiezio A, Marques ARA, Akdaş EY, Tabakacilar D, Drobny A, Werner C, Xiang W, Mächtel R, Dobert JP, Fejtova A, Richter F, Küspert M, Arnold P, Saftig P, Zunke F.

Mol Neurodegener · 2025-08-29

DOI: 10.1186/s13024-025-00886-1PMID: 40883786

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson’s disease

Evans JR, Grant-Peters M, Beckwith JS, Toomey CE, Popovic R, Breiter JC, Brenton JW, Fairbrother-Browne A, Strohbuecker S, Lachica J, Rodriguez-Lopez M, Brock EE, Fu B, Nahidiazar L, Lopez-Garcia P, Ferguson R, Saleeb RS, Lucas-Clarke H, Penverne A, D’Sa K, Pang CW, Horrocks MH, Vendruscolo M, Wood N, Lee SF, Ryten M, Gandhi S.

· 2025-08-28

DOI: 10.1101/2025.08.25.671921

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.